Skip to main content
Erschienen in: Endocrine 3/2015

01.04.2015 | Original Article

Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis

verfasst von: Husniye Baser, Ummugulsum Can, Salih Baser, Fatma Humeyra Yerlikaya, Uysaler Aslan, Bahauddin Taha Hidayetoglu

Erschienen in: Endocrine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Oxidative stress results from either overproduction of free radicals or insufficiency of several anti-oxidant defense systems. It leads to oxidation of main cellular macromolecules and a resultant molecular dysfunction. Thyroid hormones regulate oxidative metabolism and, thus, play a role in free radical production. Studies evaluating oxidative stress in patients with hypothyroidism and hyperthyroidism have been encountered in recent years; however, oxidative status in patients with euthyroid autoimmune thyroiditis (AIT) was not investigated previously. Thirty-five subjects with euthyroid AIT and 35 healthy controls were enrolled in the study. Serum oxidative status was determined by the measurement of total anti-oxidant status (TAS), total oxidant status (TOS), ischemia-modified albumin (IMA), and oxidized-low density lipoprotein (ox-LDL) levels. Serum TAS levels were significantly lower (p < 0.001), while serum TOS levels and IMA levels were significantly higher (p < 0.001 and p = 0.020, respectively) in patients compared to controls. In both groups, ox-LDL levels were similar (p = 0.608). Serum TAS levels were negatively correlated with anti-thyroid peroxidase and anti-thyroglobulin (anti-TG) levels (rho = −0.415, p = 0.001 and rho = −0.484, p < 0.001, respectively). Serum TOS was positively correlated with anti-TG levels (rho = 0.547, p < 0.001). Further, TAS was positively correlated with free T4 levels (r = 0.279, p = 0.043). No correlation was observed between thyrotropin, free T3 levels, and TOS and TAS levels. These results suggest that oxidants are increased, and anti-oxidants are decreased in patients with euthyroid AIT, and oxidative/anti-oxidative balance is shifted to the oxidative side. Increased oxidative stress might have a role in thyroid autoimmunity.
Literatur
1.
Zurück zum Zitat L. Oziol, P. Faure, N. Bertrand, P. Chomard, Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds. J. Endocrinol. 177(1), 137–146 (2003)CrossRefPubMed L. Oziol, P. Faure, N. Bertrand, P. Chomard, Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds. J. Endocrinol. 177(1), 137–146 (2003)CrossRefPubMed
2.
Zurück zum Zitat B. Halliwell, Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 344(8924), 721–724 (1994)CrossRefPubMed B. Halliwell, Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 344(8924), 721–724 (1994)CrossRefPubMed
3.
Zurück zum Zitat L. Dumitriu, R. Bartoc, H. Ursu, M. Purice, V. Lonescu, Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinologie 26(1), 35–38 (1988)PubMed L. Dumitriu, R. Bartoc, H. Ursu, M. Purice, V. Lonescu, Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinologie 26(1), 35–38 (1988)PubMed
4.
Zurück zum Zitat F. Costantini, S.D. Pierdomenico, D. De Cesare, P. De Remigis, T. Bucciarelli, G. Bittolo-Bon, G. Cazzolato, G. Nubile, M.T. Guanano, S. Sensi, F. Cuccurullo, A. Mezzetti, Effect of thyroid function on LDL oxidation. Arterioscler. Thromb. Vasc. Biol. 18(5), 732–737 (1998)CrossRefPubMed F. Costantini, S.D. Pierdomenico, D. De Cesare, P. De Remigis, T. Bucciarelli, G. Bittolo-Bon, G. Cazzolato, G. Nubile, M.T. Guanano, S. Sensi, F. Cuccurullo, A. Mezzetti, Effect of thyroid function on LDL oxidation. Arterioscler. Thromb. Vasc. Biol. 18(5), 732–737 (1998)CrossRefPubMed
5.
Zurück zum Zitat J.M. Gutteridge, Free radicals in disease processes: a compilation of cause and consequence. Free Radic. Res. Commun. 19(3), 141–158 (1993)CrossRefPubMed J.M. Gutteridge, Free radicals in disease processes: a compilation of cause and consequence. Free Radic. Res. Commun. 19(3), 141–158 (1993)CrossRefPubMed
6.
Zurück zum Zitat I. Fridovich, Superoxide anion radical (O2-), superoxide dismutases, and related matters. J. Biol. Chem. 272(30), 18515–18517 (1997)CrossRefPubMed I. Fridovich, Superoxide anion radical (O2-), superoxide dismutases, and related matters. J. Biol. Chem. 272(30), 18515–18517 (1997)CrossRefPubMed
7.
Zurück zum Zitat B.S. Berlett, E.R. Stadtman, Protein oxidation in aging, disease and oxidative stress. J. Biol. Chem. 272(33), 20313–20316 (1997)CrossRefPubMed B.S. Berlett, E.R. Stadtman, Protein oxidation in aging, disease and oxidative stress. J. Biol. Chem. 272(33), 20313–20316 (1997)CrossRefPubMed
8.
Zurück zum Zitat O. Erel, A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem. 37(4), 277–285 (2004)CrossRefPubMed O. Erel, A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem. 37(4), 277–285 (2004)CrossRefPubMed
9.
Zurück zum Zitat S.G. Ma, W. Xu, C.L. Wei, X.J. Wu, B. Hong, Z.J. Wang, H.R. Hao, H.Q. Guo, Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients. Clin. Biochem. 44(16), 1299–1303 (2011)CrossRefPubMed S.G. Ma, W. Xu, C.L. Wei, X.J. Wu, B. Hong, Z.J. Wang, H.R. Hao, H.Q. Guo, Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients. Clin. Biochem. 44(16), 1299–1303 (2011)CrossRefPubMed
10.
Zurück zum Zitat S. Turedi, O. Cinar, I. Yavuz, A. Mentese, A. Gunduz, S.C. Karahan, M. Topbas, E. Cevik, A.O. Yildirim, A. Uzun, U. Kaldirim, Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population. J. Nephrol. 23(3), 335–340 (2010)PubMed S. Turedi, O. Cinar, I. Yavuz, A. Mentese, A. Gunduz, S.C. Karahan, M. Topbas, E. Cevik, A.O. Yildirim, A. Uzun, U. Kaldirim, Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population. J. Nephrol. 23(3), 335–340 (2010)PubMed
11.
Zurück zum Zitat C.Y. Chen, W.L. Tsai, P.J. Lin, S.C. Shiesh, The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease. Clin. Chem. Lab. Med. 49(11), 1817–1821 (2011)CrossRefPubMed C.Y. Chen, W.L. Tsai, P.J. Lin, S.C. Shiesh, The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease. Clin. Chem. Lab. Med. 49(11), 1817–1821 (2011)CrossRefPubMed
12.
Zurück zum Zitat D. Bar-Or, G. Curtis, N. Rao, N. Bampos, E. Lau, Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. Eur. J. Biochem. 268(1), 42–47 (2001)CrossRefPubMed D. Bar-Or, G. Curtis, N. Rao, N. Bampos, E. Lau, Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. Eur. J. Biochem. 268(1), 42–47 (2001)CrossRefPubMed
13.
Zurück zum Zitat S. Gidenne, F. Ceppa, E. Fontan, F. Perrier, P. Burnat, Analytical performance of the albumin cobalt binding (ACB) test on the Cobas MIRA Plus analyzer. Clin. Chem. Lab. Med. 42(4), 455–461 (2004)CrossRefPubMed S. Gidenne, F. Ceppa, E. Fontan, F. Perrier, P. Burnat, Analytical performance of the albumin cobalt binding (ACB) test on the Cobas MIRA Plus analyzer. Clin. Chem. Lab. Med. 42(4), 455–461 (2004)CrossRefPubMed
14.
Zurück zum Zitat H. Esterbauer, G. Wag, H. Puhl, Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull. 49(3), 566–576 (1993)PubMed H. Esterbauer, G. Wag, H. Puhl, Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull. 49(3), 566–576 (1993)PubMed
15.
Zurück zum Zitat D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, J.L. Witztum, Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Eng. J. Med. 320(14), 915–924 (1989)CrossRef D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, J.L. Witztum, Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Eng. J. Med. 320(14), 915–924 (1989)CrossRef
16.
Zurück zum Zitat A.N. Torun, S. Kulaksizoglu, M. Kulaksizoglu, B.O. Pamuk, E. Isbilen, N.B. Tutuncu, Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin. Endocrinol. (Oxf) 70(3), 469–474 (2009)CrossRef A.N. Torun, S. Kulaksizoglu, M. Kulaksizoglu, B.O. Pamuk, E. Isbilen, N.B. Tutuncu, Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin. Endocrinol. (Oxf) 70(3), 469–474 (2009)CrossRef
17.
Zurück zum Zitat M. Aslan, N. Cosar, H. Celik, N. Aksoy, A.C. Dulger, H. Begenik, Y.U. Soyoral, M.E. Kucukoglu, S. Selek, Evaluation of oxidative status in patients with hyperthyroidism. Endocrine 40(2), 285–289 (2011)CrossRefPubMed M. Aslan, N. Cosar, H. Celik, N. Aksoy, A.C. Dulger, H. Begenik, Y.U. Soyoral, M.E. Kucukoglu, S. Selek, Evaluation of oxidative status in patients with hyperthyroidism. Endocrine 40(2), 285–289 (2011)CrossRefPubMed
18.
Zurück zum Zitat K. Ersoy, İ. Anaforoglu, E. Algün, Serum ischemic modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism. Endocrine 43(2), 430–433 (2013)CrossRefPubMed K. Ersoy, İ. Anaforoglu, E. Algün, Serum ischemic modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism. Endocrine 43(2), 430–433 (2013)CrossRefPubMed
19.
Zurück zum Zitat S.G. Ma, L.X. Yang, F. Bai, W. Xu, B. Hong, Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism. Eur. J. Intern. Med. 23(6), 136–140 (2012)CrossRef S.G. Ma, L.X. Yang, F. Bai, W. Xu, B. Hong, Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism. Eur. J. Intern. Med. 23(6), 136–140 (2012)CrossRef
20.
Zurück zum Zitat M. Lampka, R. Junik, A. Nowicka, E. Kopczyńska, T. Tyrakowski, G. Odrowaz-Sypniewska, Oxidative stress markers during a course of hyperthyroidism. Endokrynol. Pol. 57(3), 218–222 (2006)PubMed M. Lampka, R. Junik, A. Nowicka, E. Kopczyńska, T. Tyrakowski, G. Odrowaz-Sypniewska, Oxidative stress markers during a course of hyperthyroidism. Endokrynol. Pol. 57(3), 218–222 (2006)PubMed
21.
Zurück zum Zitat A. Oge, E. Sozmen, A.O. Karaoglu, Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism. Endocr. Res. 30(3), 481–489 (2004)CrossRefPubMed A. Oge, E. Sozmen, A.O. Karaoglu, Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism. Endocr. Res. 30(3), 481–489 (2004)CrossRefPubMed
22.
Zurück zum Zitat O. Erel, A new automated colorimetric method for measuring total oxidant status. Clin. Biochem. 38(12), 1103–1111 (2005)CrossRefPubMed O. Erel, A new automated colorimetric method for measuring total oxidant status. Clin. Biochem. 38(12), 1103–1111 (2005)CrossRefPubMed
23.
Zurück zum Zitat D. Bar-Or, E. Lau, J.V. Winkler, A Novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia- a preliminary report. J. Emerg. Med. 19(4), 311–315 (2000)CrossRefPubMed D. Bar-Or, E. Lau, J.V. Winkler, A Novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia- a preliminary report. J. Emerg. Med. 19(4), 311–315 (2000)CrossRefPubMed
24.
Zurück zum Zitat G. Lippi, M. Montagnana, G.L. Salvagno, G.C. Guidi, Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin. Chem. Lab. Med. 45(2), 261–262 (2007)CrossRefPubMed G. Lippi, M. Montagnana, G.L. Salvagno, G.C. Guidi, Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin. Chem. Lab. Med. 45(2), 261–262 (2007)CrossRefPubMed
25.
Zurück zum Zitat M.J. Coria, A.I. Pastán, M.S. Gimenez, Serum oxidative stress parameters of women with hypothyroidism. Acta Biomed. 80(2), 135–139 (2009)PubMed M.J. Coria, A.I. Pastán, M.S. Gimenez, Serum oxidative stress parameters of women with hypothyroidism. Acta Biomed. 80(2), 135–139 (2009)PubMed
26.
Zurück zum Zitat H. Erdamar, B. Cimen, H. Gülcemal, R. Saraymen, B. Yerer, H. Demirci, Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma. Clin. Biochem. 43(7–8), 650–654 (2010)CrossRefPubMed H. Erdamar, B. Cimen, H. Gülcemal, R. Saraymen, B. Yerer, H. Demirci, Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma. Clin. Biochem. 43(7–8), 650–654 (2010)CrossRefPubMed
27.
Zurück zum Zitat L.E. Laatikainen, M.D. Castellone, A. Hebrant, C. Hoste, M.C. Cantisani, J.P. Laurila, G. Salvatore, P. Salerno, F. Basolo, J. Näsman, J.E. Dumont, M. Santoro, M.O. Laukkanen, Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer. Endocr. Relat. Cancer 17(3), 785–796 (2010)CrossRefPubMed L.E. Laatikainen, M.D. Castellone, A. Hebrant, C. Hoste, M.C. Cantisani, J.P. Laurila, G. Salvatore, P. Salerno, F. Basolo, J. Näsman, J.E. Dumont, M. Santoro, M.O. Laukkanen, Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer. Endocr. Relat. Cancer 17(3), 785–796 (2010)CrossRefPubMed
28.
Zurück zum Zitat O. Young, T. Crotty, R. O’Connell, J. O’Sullivan, A.J. Curran, Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 32(6), 750–756 (2010)PubMed O. Young, T. Crotty, R. O’Connell, J. O’Sullivan, A.J. Curran, Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 32(6), 750–756 (2010)PubMed
29.
Zurück zum Zitat E. Carmeli, A. Bachar, S. Barchad, M. Morad, J. Merrick, Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: a pilot study. Res. Dev. Disabil. 29(5), 431–438 (2008)CrossRefPubMed E. Carmeli, A. Bachar, S. Barchad, M. Morad, J. Merrick, Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: a pilot study. Res. Dev. Disabil. 29(5), 431–438 (2008)CrossRefPubMed
30.
Zurück zum Zitat A. Saad-Hussein, H. Hamdy, H.M. Aziz, H. Mahdy-Abdallah, Thyroid functions in paints production workers and the mechanism of oxidative-antioxidants status. Toxicol. Ind. Health 27(3), 257–263 (2011)CrossRefPubMed A. Saad-Hussein, H. Hamdy, H.M. Aziz, H. Mahdy-Abdallah, Thyroid functions in paints production workers and the mechanism of oxidative-antioxidants status. Toxicol. Ind. Health 27(3), 257–263 (2011)CrossRefPubMed
31.
Zurück zum Zitat C. Marcocci, L. Bartalena, Role of oxidative stress and selenium in Graves’ hyperthyroidism and orbitopathy. J. Endocrinol. Invest. 36(10 Suppl), 15–20 (2013)PubMed C. Marcocci, L. Bartalena, Role of oxidative stress and selenium in Graves’ hyperthyroidism and orbitopathy. J. Endocrinol. Invest. 36(10 Suppl), 15–20 (2013)PubMed
32.
Zurück zum Zitat A. Kaur, S. Pandey, S. Kumar, A.A. Mehdi, A. Mishra, Oxidative stress profile in graves’ ophthalmopathy in Indian patients. Orbit 29(2), 97–101 (2010)CrossRefPubMed A. Kaur, S. Pandey, S. Kumar, A.A. Mehdi, A. Mishra, Oxidative stress profile in graves’ ophthalmopathy in Indian patients. Orbit 29(2), 97–101 (2010)CrossRefPubMed
33.
Zurück zum Zitat B. Pereira, L.F. Rosa, D.A. Safi, E.L. Bechara, R. Curi, Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J. Endocrinol. 140(1), 73–77 (1994)CrossRefPubMed B. Pereira, L.F. Rosa, D.A. Safi, E.L. Bechara, R. Curi, Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J. Endocrinol. 140(1), 73–77 (1994)CrossRefPubMed
34.
Zurück zum Zitat A. Swaroop, T. Ramasarma, Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Biochem. J. 226(2), 403–408 (1985)PubMedCentralPubMed A. Swaroop, T. Ramasarma, Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Biochem. J. 226(2), 403–408 (1985)PubMedCentralPubMed
35.
Zurück zum Zitat V.S. Reddy, S. Gouroju, M.M. Suchitra, V. Suresh, A. Sachan, P.V. Srinivasa Rao, A.R. Bitla, Antioxidant defense in overt and subclinical hypothyroidism. Horm. Metab. Res. 45(10), 754–758 (2013)CrossRefPubMed V.S. Reddy, S. Gouroju, M.M. Suchitra, V. Suresh, A. Sachan, P.V. Srinivasa Rao, A.R. Bitla, Antioxidant defense in overt and subclinical hypothyroidism. Horm. Metab. Res. 45(10), 754–758 (2013)CrossRefPubMed
36.
Zurück zum Zitat M. Kaçmaz, M. Atmaca, A. Arslan, H. Demir, M.F. Ozbay, Oxidative stress in patients with thyroidectomy and thyroparathyroidectomy under replacement therapy. Endocrine. (2014). doi:10.1007/s12020-014-0270-6 M. Kaçmaz, M. Atmaca, A. Arslan, H. Demir, M.F. Ozbay, Oxidative stress in patients with thyroidectomy and thyroparathyroidectomy under replacement therapy. Endocrine. (2014). doi:10.​1007/​s12020-014-0270-6
37.
Zurück zum Zitat M. Oncel, A. Kıyıcı, S. Onen, Evaluation of the Relationship Between Ischemia-Modified Albumin Levels and Thyroid Hormone Levels. J. Clin. Lab. Anal. (2014). doi:10.1002/jcla.21789 PubMed M. Oncel, A. Kıyıcı, S. Onen, Evaluation of the Relationship Between Ischemia-Modified Albumin Levels and Thyroid Hormone Levels. J. Clin. Lab. Anal. (2014). doi:10.​1002/​jcla.​21789 PubMed
38.
Zurück zum Zitat N.I. Krinsky, Mechanism of action of biological antioxidants. Proc. Soc. Exp. Biol. Med. 200(2), 248–254 (1992)CrossRefPubMed N.I. Krinsky, Mechanism of action of biological antioxidants. Proc. Soc. Exp. Biol. Med. 200(2), 248–254 (1992)CrossRefPubMed
39.
Zurück zum Zitat B. Halliwell, J.M. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186, 1–85 (1990)CrossRefPubMed B. Halliwell, J.M. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186, 1–85 (1990)CrossRefPubMed
40.
Zurück zum Zitat U. Resch, G. Helsel, F. Tatzber, H. Sinzinger, Antioxidant status in thyroid dysfunction. Clin. Chem. Lab. Med. 40(11), 1132–1134 (2002)CrossRefPubMed U. Resch, G. Helsel, F. Tatzber, H. Sinzinger, Antioxidant status in thyroid dysfunction. Clin. Chem. Lab. Med. 40(11), 1132–1134 (2002)CrossRefPubMed
41.
Zurück zum Zitat V. Sundaram, A.N. Hanna, L. Koneru, H.A. Newman, J.M. Falko, Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J. Clin. Endocrinol. Metab. 82(10), 3421–3424 (1997)PubMed V. Sundaram, A.N. Hanna, L. Koneru, H.A. Newman, J.M. Falko, Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J. Clin. Endocrinol. Metab. 82(10), 3421–3424 (1997)PubMed
42.
Zurück zum Zitat T. Diekman, P.N. Demacker, J.J. Kastelein, A.F. Stalenhoef, W.M. Wiersinga, Increased oxidizability of low-density lipoproteins in hypothyroidism. J. Clin. Endocrinol. Metab. 83(5), 1752–1755 (1998)CrossRefPubMed T. Diekman, P.N. Demacker, J.J. Kastelein, A.F. Stalenhoef, W.M. Wiersinga, Increased oxidizability of low-density lipoproteins in hypothyroidism. J. Clin. Endocrinol. Metab. 83(5), 1752–1755 (1998)CrossRefPubMed
44.
Zurück zum Zitat D. Shah, N. Mahajan, S. Sah, S.K. Nath, B. Paudyal, Oxidative stress and its biomarkers in systemic lupus erythematosus. J. Biomed. Sci. 21, 23 (2014)CrossRefPubMedCentralPubMed D. Shah, N. Mahajan, S. Sah, S.K. Nath, B. Paudyal, Oxidative stress and its biomarkers in systemic lupus erythematosus. J. Biomed. Sci. 21, 23 (2014)CrossRefPubMedCentralPubMed
45.
Zurück zum Zitat N.C. Laddha, M. Dwivedi, M.S. Mansuri, A.R. Gani, M. Ansarullah, A.V. Ramachandran, S. Dalai, R. Begum, Vitiligo: interplay between oxidative stress and immune system. Exp. Dermatol. 22(4), 245–250 (2013)CrossRefPubMed N.C. Laddha, M. Dwivedi, M.S. Mansuri, A.R. Gani, M. Ansarullah, A.V. Ramachandran, S. Dalai, R. Begum, Vitiligo: interplay between oxidative stress and immune system. Exp. Dermatol. 22(4), 245–250 (2013)CrossRefPubMed
46.
Zurück zum Zitat B. Zhang, C. Lo, L. Shen, R. Sood, C. Jones, K. Cusmano-Ozog, S. Park-Snyder, W. Wong, M. Jeng, T. Cowan, E.G. Engleman, J.L. Zehnder, The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood 117(17), 4569–4579 (2011)CrossRefPubMed B. Zhang, C. Lo, L. Shen, R. Sood, C. Jones, K. Cusmano-Ozog, S. Park-Snyder, W. Wong, M. Jeng, T. Cowan, E.G. Engleman, J.L. Zehnder, The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood 117(17), 4569–4579 (2011)CrossRefPubMed
47.
48.
Zurück zum Zitat R. Rostami, M.R. Aghasi, A. Mohammadi, J. Nourooz-Zadeh, Enhanced oxidative stress in Hashimoto’s thyroiditis: inter-relationships to biomarkers of thyroid function. Clin. Biochem. 46(4–5), 308–312 (2013)CrossRefPubMed R. Rostami, M.R. Aghasi, A. Mohammadi, J. Nourooz-Zadeh, Enhanced oxidative stress in Hashimoto’s thyroiditis: inter-relationships to biomarkers of thyroid function. Clin. Biochem. 46(4–5), 308–312 (2013)CrossRefPubMed
49.
Zurück zum Zitat G. Vitale, S. Salvioli, C. Franceschi, Oxidative stress and the ageing endocrine system. Nat. Rev. Endocrinol. 9(4), 228–240 (2013)CrossRefPubMed G. Vitale, S. Salvioli, C. Franceschi, Oxidative stress and the ageing endocrine system. Nat. Rev. Endocrinol. 9(4), 228–240 (2013)CrossRefPubMed
50.
Zurück zum Zitat P. Mitrou, S.A. Raptis, G. Dimitriadis, Thyroid disease in older people. Maturitas 70(1), 5–9 (2011)CrossRefPubMed P. Mitrou, S.A. Raptis, G. Dimitriadis, Thyroid disease in older people. Maturitas 70(1), 5–9 (2011)CrossRefPubMed
51.
Zurück zum Zitat C. Duthoit, V. Estienne, A. Giraud, J.M. Durand-Gorde, A.K. Rasmussen, U. Feldt-Rasmussen, P. Carayon, J. Ruf, Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity? Biochem. J. 360(Pt 3), 557–562 (2001)CrossRefPubMedCentralPubMed C. Duthoit, V. Estienne, A. Giraud, J.M. Durand-Gorde, A.K. Rasmussen, U. Feldt-Rasmussen, P. Carayon, J. Ruf, Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity? Biochem. J. 360(Pt 3), 557–562 (2001)CrossRefPubMedCentralPubMed
52.
Zurück zum Zitat C.L. Burek, N.R. Rose, Autoimmune thyroiditis and ROS. Autoimmun. Rev. 7(7), 530–537 (2008)CrossRefPubMed C.L. Burek, N.R. Rose, Autoimmune thyroiditis and ROS. Autoimmun. Rev. 7(7), 530–537 (2008)CrossRefPubMed
54.
Zurück zum Zitat B. Halliwell, The wanderings of a free radical. Free Radic. Biol. Med. 46(5), 531–542 (2009)CrossRefPubMed B. Halliwell, The wanderings of a free radical. Free Radic. Biol. Med. 46(5), 531–542 (2009)CrossRefPubMed
55.
Zurück zum Zitat K. Schlesier, M. Harwat, V. Böhm, R. Bitsch, Assessment of antioxidant activity by using different in vitro methods. Free Radic. Res. 36(2), 177–187 (2002)CrossRefPubMed K. Schlesier, M. Harwat, V. Böhm, R. Bitsch, Assessment of antioxidant activity by using different in vitro methods. Free Radic. Res. 36(2), 177–187 (2002)CrossRefPubMed
56.
Zurück zum Zitat R.L. Prior, G. Cao, In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic. Biol. Med. 27(11–12), 1173–1181 (1999)CrossRefPubMed R.L. Prior, G. Cao, In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic. Biol. Med. 27(11–12), 1173–1181 (1999)CrossRefPubMed
57.
Zurück zum Zitat D. Wang, J.F. Feng, P. Zeng, Y.H. Yang, J. Luo, Y.W. Yang, Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr. Relat. Cancer 18(6), 773–782 (2011)CrossRefPubMedCentralPubMed D. Wang, J.F. Feng, P. Zeng, Y.H. Yang, J. Luo, Y.W. Yang, Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr. Relat. Cancer 18(6), 773–782 (2011)CrossRefPubMedCentralPubMed
Metadaten
Titel
Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis
verfasst von
Husniye Baser
Ummugulsum Can
Salih Baser
Fatma Humeyra Yerlikaya
Uysaler Aslan
Bahauddin Taha Hidayetoglu
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0399-3

Weitere Artikel der Ausgabe 3/2015

Endocrine 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.